Western Point Pharmaceutical: Shareholders holding more than 5% of shares have had their shares frozen by the judiciary.

Jin10 data October 15th news, West Point Pharmaceuticals announced that the shares held by its major shareholder, Hengqin Dingdian Equity Investment Fund Partnership (Limited Partnership), which owns more than 5% of the shares, have been judicially frozen. The number of frozen shares this time is 2.567 million shares, accounting for 42.69% of its holdings and 3.36% of the total share capital of the company. The total number of shares frozen for Hengqin Dingdian is 2.567 million shares, accounting for 42.69% of its holdings and 3.36% of the total share capital of the company. The reason for this freeze is related to litigation, with the freeze period from October 13, 2025, to October 12, 2028. Hengqin Dingdian is not the company's controlling shareholder or actual controller, and this share freeze will not lead to a change in the company's control nor will it adversely affect the company's ongoing operations.